Sodium Valproate
R. M. Pinder, Rex N. Brogden, T.M. Speight et al. · Drugs · 1977
Cited by 315 works. doi:10.2165/00003495-197713020-00001
Authors
References
- Clinical and Electroencephalographical Classification of Epileptic Seizures
- Sodium Di‐N‐Propylacetate (DPA) in the Treatment of Epilepsy:A Review
- EFFECTS OF DI‐n‐PROPYLACETATE, AN ANTICONVULSIVE COMPOUND, ON GABA METABOLISM1
- [Pharmacodynamic properties of N-dipropylacetic acid].
- Sodium Valproate in Treatment of Epilepsy
- Effect of sodium n-dipropylacetate on audiogenic seizures and brain γ-aminobutyric acid level
- Epilepsy and γ-Aminobutyric Acid-Mediated Inhibition
- Dipropylacetate (Depakine®, Ergenyl®) in the Treatment of Epilepsy
- Pharmacokinetics of di-n-propylacetate in epileptic patients
- Treatment of Generalized Epilepsies of Childhood and Adolescence with Sodium Valproate (‘Epilim’)